Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2L6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,001
Award facts
- Contract value 100% obligated
- $18,001.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,001.13 to AmerisourceBergen Drug Corp for the supply of Cosentyx Unoready 300 mg pen 2ml, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by January 15, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program—valued at $999,999,999.00 through December 2026, which serves as the comprehensive procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. The competitive award of this delivery order reflects AmerisourceBergen's ability to meet federal procurement requirements for essential pharmaceutical supplies supporting military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FA2L6?
SPE2DR26FA2L6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FA2L6 worth?
The government has obligated $18,001 on SPE2DR26FA2L6.
Is contract SPE2DR26FA2L6 an order under another contract?
Yes. SPE2DR26FA2L6 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2L6 competed?
The extent of competition for SPE2DR26FA2L6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award